FIELD: medicine.
SUBSTANCE: invention concerns using a pharmaceutical combination of an angiotensin-converting enzyme inhibitor and a pineal hormone for treating ischemic heart disease (IHD) in elderly patients. What is declared is using fozinopril 10 mg 2 times a day at 8.00 am and at 8.00 pm, and melatonin 3 mg half an hour before going to bed once a day.
EFFECT: reducing the length of the therapeutic therapy of IHD in the elderly patients and normalising the state within 12-14 days.
4 ex
Authors
Dates
2015-05-10—Published
2013-08-27—Filed